EMA Authorised: Atazanavir Viatris (previously Atazanavir Mylan) (atazanavir (as sulfate)) — Viatris Limited

View source ↗

Summary

EMA authorised Atazanavir Viatris (atazanavir sulfate) for HIV infections; Viatris Limited is the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atazanavir Viatris (atazanavir sulfate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 14/05/2025